Clinical Trial Update: Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and effectiveness of intravitreal bevacizumab for macular edema due to retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 3 | Status: COMPLETED